Home / Topiramate / Czechia
CZ ATC N03AX11 · updated 2 Nov 2026
Topiramate shortage in Czechia
Is there a Topiramate shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Topiramate products are reported short in Czechia, the first since 15 Dec 2025. The company estimate for the return is 16 Nov 2026 (latest 11 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Austria, Belgium, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TOPIRAMAT MYLAN 50MG 50MG TBL FLM 60 | VIATRIS LIMITED, Dublin | 15 Dec 2025 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | TOPIMARK 100MG 100MG TBL FLM 30 | Glenmark Pharmaceuticals s.r.o., Praha | 1 Sep 2026 | 16 Nov 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | TOPAMAX 50MG 50MG TBL FLM 60 anticipated | Janssen-Cilag s.r.o., Praha | 13 Nov 2026 | 11 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.